Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

C.L. Andersen; M.E. Bjorn; M.F. McMullin; C. Harrison; J. Samuelsson; E. Ejerblad; S. Zweegman; S. Fernandes; D. Bareford; S. Knapper; E. Lofvenberg; O. Linder; B. Andreasson; E. Ahlstrand; M.K. Jensen; O.W. Bjerrum; H. Vestergaard; H. Larsen; T.W. Klausen; T. Mourits-Andersen; V. Skov; M. Thomassen; T. Kruse; K. Gronbaek; H.C. Hasselbalch

doi:10.1016/j.leukres.2014.04.002

Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

C.L. Andersen, M.E. Bjorn, M.F. McMullin, C. Harrison, J. Samuelsson, E. Ejerblad, S. Zweegman, S. Fernandes, D. Bareford, S. Knapper, E. Lofvenberg, O. Linder, B. Andreasson, E. Ahlstrand, M.K. Jensen, O.W. Bjerrum, H. Vestergaard, H. Larsen, T.W. Klausen, T. Mourits-AndersenV. Skov, M. Thomassen, T. Kruse, K. Gronbaek, H.C. Hasselbalch

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	816-821
Journal	Leukemia Research
Volume	38
Issue number	7
DOIs	https://doi.org/10.1016/j.leukres.2014.04.002
Publication status	Published - 2014

Access to Document

10.1016/j.leukres.2014.04.002

Cite this

Andersen, C. L., Bjorn, M. E., McMullin, M. F., Harrison, C., Samuelsson, J., Ejerblad, E., Zweegman, S., Fernandes, S., Bareford, D., Knapper, S., Lofvenberg, E., Linder, O., Andreasson, B., Ahlstrand, E., Jensen, M. K., Bjerrum, O. W., Vestergaard, H., Larsen, H., Klausen, T. W., ... Hasselbalch, H. C. (2014). Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat. Leukemia Research, 38(7), 816-821. https://doi.org/10.1016/j.leukres.2014.04.002

@article{28db3168ead2487a8f29a85faa679024,

title = "Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat",

author = "C.L. Andersen and M.E. Bjorn and M.F. McMullin and C. Harrison and J. Samuelsson and E. Ejerblad and S. Zweegman and S. Fernandes and D. Bareford and S. Knapper and E. Lofvenberg and O. Linder and B. Andreasson and E. Ahlstrand and M.K. Jensen and O.W. Bjerrum and H. Vestergaard and H. Larsen and T.W. Klausen and T. Mourits-Andersen and V. Skov and M. Thomassen and T. Kruse and K. Gronbaek and H.C. Hasselbalch",

year = "2014",

doi = "10.1016/j.leukres.2014.04.002",

language = "Undefined/Unknown",

volume = "38",

pages = "816--821",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Limited",

number = "7",

}

Andersen, CL, Bjorn, ME, McMullin, MF, Harrison, C, Samuelsson, J, Ejerblad, E, Zweegman, S, Fernandes, S, Bareford, D, Knapper, S, Lofvenberg, E, Linder, O, Andreasson, B, Ahlstrand, E, Jensen, MK, Bjerrum, OW, Vestergaard, H, Larsen, H, Klausen, TW, Mourits-Andersen, T, Skov, V, Thomassen, M, Kruse, T, Gronbaek, K & Hasselbalch, HC 2014, 'Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat', Leukemia Research, vol. 38, no. 7, pp. 816-821. https://doi.org/10.1016/j.leukres.2014.04.002

TY - JOUR

T1 - Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

AU - Andersen, C.L.

AU - Bjorn, M.E.

AU - McMullin, M.F.

AU - Harrison, C.

AU - Samuelsson, J.

AU - Ejerblad, E.

AU - Zweegman, S.

AU - Fernandes, S.

AU - Bareford, D.

AU - Knapper, S.

AU - Lofvenberg, E.

AU - Linder, O.

AU - Andreasson, B.

AU - Ahlstrand, E.

AU - Jensen, M.K.

AU - Bjerrum, O.W.

AU - Vestergaard, H.

AU - Larsen, H.

AU - Klausen, T.W.

AU - Mourits-Andersen, T.

AU - Skov, V.

AU - Thomassen, M.

AU - Kruse, T.

AU - Gronbaek, K.

AU - Hasselbalch, H.C.

PY - 2014

Y1 - 2014

U2 - 10.1016/j.leukres.2014.04.002

DO - 10.1016/j.leukres.2014.04.002

M3 - Article

C2 - 24836761

VL - 38

SP - 816

EP - 821

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 7

ER -